Lincoln Pharmaceuticals Ltd

BSE: 531633

109

total announcements

LINCOLN.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 09 Nov 2026

Market Cap

₹1,030 Cr

P/E (TTM)

10.6

EPS (TTM)

₹48.38

52W Low

₹439.95

52W High

₹770.00

Dividend Yield

0.35%

Beta

0.52

Price / Book

1.3

Return on Equity

12.69%

Debt / Equity

0.4

Revenue (TTM)

₹722 Cr

Gross Margin

50.74%

Operating Margin

10.35%

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has announced the appointment of a new Senior General Manager.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany Update24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the appointment of a Sr. General Manager. This is a routine update and does not have a significant impact on the company's financials or operations.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has announced the appointment of a new Senior General Manager.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager. The details are not provided.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a new Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a new Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a new Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a new Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a new Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a Sr. General Manager - XBRL.